Editorial: Mitochondria and subcellular organelles as treatment targets against pathological conditions

Current Pharmaceutical Design

Volumn 20, Issue 2, 2014, Pages 153-

  Toninello, Antonio ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE NUCLEOTIDE TRANSLOCASE; CERAMIDE; CISPLATIN; HYDROGEN PEROXIDE; MONOAMINE OXIDASE INHIBITOR; REACTIVE OXYGEN METABOLITE; STAUROSPORINE;

APOPTOSIS; CANCER CELL; CANCER GROWTH; CELL DEATH; CELL ENERGY; CELL MEMBRANE; CELL ORGANELLE; CELL PROLIFERATION; DEGENERATIVE DISEASE; EDITORIAL; ENERGY TRANSFER; HOMEOSTASIS; HUMAN; INTRACELLULAR SIGNALING; METABOLISM; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL PERMEABILITY; MITOCHONDRION; POLYAMINE METABOLISM; PRIORITY JOURNAL; PROSTATE CANCER; RNA INTERFERENCE; SUBCELLULAR ORGANELLE;

HUMANS; MITOCHONDRIA; MOLECULAR TARGETED THERAPY; ORGANELLES; SUBCELLULAR FRACTIONS;

EID: 84892979245     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/13816128113199990038     Document Type: Editorial

References (13)

1. Edmondson DE. Hydrogen peroxide produced by mitochondrial monoamine oxidase catalysis: biological implications. Curr Pharm Des 2014; 20(2): 155-60.
2. Stasiak A, Mussur M, Unzeta M, Samadi A, Marco-Contelles JL, Fogel WA. Effects of novel monoamine oxidases and cholinesterases targeting compounds on brain neurotransmitters and behavior in rat model of vascular dementia. Curr Pharm Des 2014; 20(2): 161-71.
3. Sassi N, Mattarei A, Azzolini M, Bernardi P, Szabo' I, Paradisi C, Zoratti M, Biasutto L. Mitochondria-targeted resveratrol derivatives act as cytotoxic pro-oxidants. Curr Pharm Des 2014; 20(2): 172-9.
4. Arisan ED, Obakan P, Coker-Gürkan A, Calcabrini A, Agostinelli E, Unsal NP. CDK inhibitors induce mitochondria-mediated apoptosis through the activation of polyamine catabolic pathway in LNCaP, DU145 and PC3 prostate cancer cells. Curr Pharm Des 2014; 20(2): 180-8.
5. Leanza L, O'Reilly P, Doyle A, Venturini E, Zoratti M, Szegezdi E, Szabò I. Correlation between potassium channel expression and sensitivity to drug-induced cell death in tumor cell lines. Curr Pharm Des 2014; 20(2): 189-200.
6. Ubah OC, Wallace HM. Cancer Therapy: Targeting mitochondria and other sub-cellular organelles. Curr Pharm Des 2014; 20(2): 201-22.
7. Dalla Via L, García-Argáez AN, Martínez-Vázquez M, Grancara S, Martinis P, Toninello A. Mitochondrial permeability transition as target of anticancer drugs. Curr Pharm Des 2014; 20(2): 223-44.
8. Perez-Leal O, Abou-Gharbia M, Gordon J, Childers WE, Merali S. A novel assay platform for the detection of translation modulators of spermidine/spermine acetyltransferase. Curr Pharm Des 2014; 20(2): 245-52.
9. Dalla Via L, García-Argáez AN, Braga A, Martínez-Vázquez M, Grancara S, Martinis P, Agostinelli E, Toninello A. An eudesman derivative from Verbesina persicifolia D. C. as a natural mild uncoupler in liver mitochondria. A new potential anti-obesity agent? Curr Pharm Des 2014; 20(2): 253-61.
10. Weisell J, Hyvönen MT, Alhonen L, Vepsäläinen J, Keinänen TA, Khomutov AR. Charge deficient analogues of the natural polyamines. Curr Pharm Des 2014; 20(2): 262-77.
11. Mueller A-K, Hammerschmidt-Kamper C, Kaiser A. RNAi in Plasmodium. Curr Pharm Des 2014; 20(2): 278-83.
12. Almeida OP Jr, Toledo TR, Rossi D, de Barros Rossetto D, Watanabe TF, Carrilho Galvão F, Medeiros AI, CF Zanelli, Valentini SR. Hypusine modification of the ribosome-binding protein eIF5A, a target for new anti-inflammatory drugs: understanding the action of the inhibitor GC7 on a murine macrophage cell line. Curr Pharm Des 2014; 20(2): 284-92.
13. Sánchez-Jiménez F, Reyes-Palomares A, Moya-García A, Ranea JAG, Medina M. Biocomputational Resources Useful For Drug Discovery Against Compartmentalized Targets. Curr Pharm Des 2014; 20(2): 293-300.